千金药业：2025年三季度披露财务报表未将收购部分股权的利润纳入归母净利润

Group 1 - The core viewpoint of the article is that Qianjin Pharmaceutical clarified that the profits from the acquisition of certain equity stakes will not be included in the net profit attributable to the parent company in the financial report for the third quarter of 2025 [1] - The financial profits from the two equity acquisitions will start to be consolidated in the financial statements in October and November 2025 respectively [1]